Pvs230D1-EPA/MM Phase 1 Study
A new vaccine is needed to stop the spread of malaria. Malaria is a dangerous disease that impacts hundreds of millions of people in Africa, Asia, and Latin America. It can cause severe disease and even death. Researchers at NIH's Laboratory of Malaria Immunology and Vaccinology are seeking healthy volunteers to be part of a malaria vaccine research study. Malaria is spread to humans after they are bitten by an infected mosquito. Likewise, a mosquito picks up malaria when they bite an infected person. For this study, researchers are working on developing a new, investigational vaccine with the goal of breaking this cycle and stopping the spread of this disease.
You may be eligible if you:
- Are between the ages of 18 and 50
- Live in the Washington D.C. metro area
- Are in good general health
Study participation will include:
- 3 doses of an investigational vaccine
- Follow-up clinic visits with blood draws
- Follow-up phone calls
- No risk of developing malaria from this vaccine
Compensation will be provided.
To learn more, call:
NIH Clinical Center Office of Patient Recruitment
800-411-1222
(TTY users dial 7-1-1)
Email: ccopr@nih.gov
Or go online:
https://bit.ly/3Z94WFV
Refer to study # 001501-I
Department of Health and Human Services
National Institutes of Health Clinical Center (CC)
National Institute of Allergy and Infectious Diseases (NIAID)